Effectiveness of Growth-Promoting Therapies
- 1 February 1991
- journal article
- clinical trial
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 145 (2) , 168-171
- https://doi.org/10.1001/archpedi.1991.02160020060017
Abstract
• The ability of growth hormone, clonidine, and levodopa to stimulate growth was compared in short and slowly growing children randomly assigned to different treatment regimens for 6 months. There were 10 children in each group, and 10 additional subjects served as controls. Growth hormone improved mean height velocity, height velocity SD score, and height SD score. The mean height velocity and height velocity SD score were significantly increased by clonidine, while levodopa only enhanced the mean height velocity SD score of the treated children. Moreover, in nine patients (90%) receiving growth hormone, two (20%) receiving clonidine, and one (10%) receiving levodopa, the height velocity was raised by more than 2 cm/y. The increments in height velocity and height SD score were greatest in the growth hormone group. Clonidine induced an increase in height velocity significantly different from that in control children only. In the control group, there was a significant reduction of height SD score with time. (AJDC. 1991;145:168–171)Keywords
This publication has 11 references indexed in Scilit:
- LACK OF BENEFIT OF CLONIDINE TREATMENT FOR SHORT STATURE IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALThe Lancet, 1988
- GROWTH HORMONE SECRETION IN CHILDREN DETERMINED BY TIME SERIES ANALYSISClinical Endocrinology, 1988
- Effect of growth hormone on short normal children.BMJ, 1987
- Growth hormone treatment and the short child: To treat or not to treat?The Journal of Pediatrics, 1987
- Short-term treatment of short stature and subnormal growth rate with human growth hormoneThe Journal of Pediatrics, 1987
- Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delayThe Journal of Pediatrics, 1986
- WHICH CHILDREN SHOULD HAVE GROWTH HORMONE THERAPY?The Lancet, 1986
- Growth Enhancement by Dopaminergic Therapy in Children with Intrauterine Growth Retardation*Journal of Clinical Endocrinology & Metabolism, 1985
- Growth hormone-dependent growth failureThe Journal of Pediatrics, 1982
- Children with Normal-Variant Short Stature: Treatment with Human Growth Hormone for Six MonthsNew England Journal of Medicine, 1981